The role of transcription factors in prostate cancer and potential for future RNA interference therapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of transcription factors in prostate cancer and potential for future RNA interference therapy
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 18, Issue 6, Pages 633-649
Publisher
Informa Healthcare
Online
2014-03-25
DOI
10.1517/14728222.2014.896904
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate cancer: ESMO Consensus Conference Guidelines 2012
- (2013) A. Horwich et al. ANNALS OF ONCOLOGY
- YB-1: oncoprotein, prognostic marker and therapeutic target?
- (2013) Annette Lasham et al. BIOCHEMICAL JOURNAL
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer
- (2013) C Yang et al. CANCER GENE THERAPY
- Androgen-responsive Serum Response Factor target genes regulate prostate cancer cell migration
- (2013) A. R. Verone et al. CARCINOGENESIS
- Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site
- (2013) Kurtis Eisermann et al. Molecular Cancer
- Identification of transcription factors associated with castration-resistance: Is the serum responsive factor a potential therapeutic target?
- (2013) Maria Prencipe et al. PROSTATE
- Delivering RNAi therapeutics with non-viral technology: a promising strategy for prostate cancer?
- (2013) Jianfeng Guo et al. TRENDS IN MOLECULAR MEDICINE
- Overexpression of Forkhead Box M1 Transcription Factor (FOXM1) is a Potential Prognostic Marker and Enhances Chemoresistance for Docetaxel in Gastric Cancer
- (2012) Kaoru Okada et al. ANNALS OF SURGICAL ONCOLOGY
- Targeting FOXM1 in cancer
- (2012) Marianna Halasi et al. BIOCHEMICAL PHARMACOLOGY
- Y-box-binding protein 1 (YB-1) and its functions
- (2012) I. A. Eliseeva et al. BIOCHEMISTRY-MOSCOW
- Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice
- (2012) Jianfeng Guo et al. BIOMATERIALS
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Translation Initiation Factor eIF4E Is a Target for Tumor Cell Radiosensitization
- (2012) T. J. Hayman et al. CANCER RESEARCH
- NF-κB and the link between inflammation and cancer
- (2012) Joseph A. DiDonato et al. IMMUNOLOGICAL REVIEWS
- Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer
- (2012) Neha Singh et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inverse Relationship between PSA and IL-8 in Prostate Cancer: An Insight into a NF-κB-Mediated Mechanism
- (2012) Yong Xu et al. PLoS One
- Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer
- (2012) Anastasia Malek et al. PLoS One
- Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer
- (2012) Jordi Codony-Servat et al. PROSTATE
- Transcriptional repression of RUNX2 is associated with aggressive clinicopathological outcomes, whereas nuclear location of the protein is related to metastasis in prostate cancer
- (2012) S J Yun et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Therapeutic Options for Advanced Prostate Cancer: 2011 Update
- (2012) Aurelius Omlin et al. Current Urology Reports
- Overcoming docetaxel resistance in prostate cancer: a perspective review
- (2012) Clara Hwang Therapeutic Advances in Medical Oncology
- Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?
- (2011) Jianfeng Guo et al. BIOTECHNOLOGY ADVANCES
- Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
- (2011) H. V. Heemers et al. CANCER RESEARCH
- New treatment options for patients with metastatic castration-resistant prostate cancer
- (2011) Celestia S. Higano CANCER TREATMENT REVIEWS
- FGFR-4 Arg388 Enhances Prostate Cancer Progression via Extracellular Signal-Related Kinase and Serum Response Factor Signaling
- (2011) W. Yu et al. CLINICAL CANCER RESEARCH
- Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-l-lysine nanocarrier to suppress prostate cancer growth in mice
- (2011) Jianfeng Guo et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells
- (2011) Bin Bao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Targeting SP1 Transcription Factor in Prostate Cancer Therapy
- (2011) Umesh T. Sankpal et al. Medicinal Chemistry
- Interleukin-6: A multifunctional targetable cytokine in human prostate cancer
- (2011) Zoran Culig et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Transcription Factor Stat5 Knockdown Enhances Androgen Receptor Degradation and Delays Castration-Resistant Prostate Cancer Progression In vivo
- (2011) C. Thomas et al. MOLECULAR CANCER THERAPEUTICS
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- NF-κB signaling in prostate cancer: A promising therapeutic target?
- (2011) Garima Jain et al. WORLD JOURNAL OF UROLOGY
- RNAi-Based Treatment for Neovascular Age-Related Macular Degeneration by Sirna-027
- (2010) Peter K. Kaiser et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Transcription Factor Stat3 Stimulates Metastatic Behavior of Human Prostate Cancer Cells in Vivo, whereas Stat5b Has a Preferential Role in the Promotion of Prostate Cancer Cell Viability and Tumor Growth
- (2010) Lei Gu et al. AMERICAN JOURNAL OF PATHOLOGY
- Prioritizing genes associated with prostate cancer development
- (2010) Ivan P Gorlov et al. BMC CANCER
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting Eukaryotic Translation Initiation Factor 4E (eIF4E) in Cancer
- (2010) A. C. Hsieh et al. CLINICAL CANCER RESEARCH
- Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches
- (2010) Stephen Y. Lai et al. DRUG RESISTANCE UPDATES
- Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo
- (2010) Lei Gu et al. ENDOCRINE-RELATED CANCER
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Biomaterials offer cancer research the third dimension
- (2010) Dietmar W. Hutmacher NATURE MATERIALS
- Drug resistance in metastatic castration-resistant prostate cancer
- (2010) Bostjan Seruga et al. Nature Reviews Clinical Oncology
- Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E
- (2010) C Andrieu et al. ONCOGENE
- eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
- (2010) L. Furic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of transcription factor selectivity
- (2010) Yongping Pan et al. TRENDS IN GENETICS
- NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth
- (2009) Liying Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
- (2009) Heehyoung Lee et al. CANCER CELL
- RelB Enhances Prostate Cancer Growth: Implications for the Role of the Nuclear Factor- B Alternative Pathway in Tumorigenicity
- (2009) Y. Xu et al. CANCER RESEARCH
- Critical Role and Regulation of Transcription Factor FoxM1 in Human Gastric Cancer Angiogenesis and Progression
- (2009) Q. Li et al. CANCER RESEARCH
- eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival
- (2009) J. R. Graff et al. CANCER RESEARCH
- Forkhead box M1 transcription factor: A novel target for cancer therapy
- (2009) Zhiwei Wang et al. CANCER TREATMENT REVIEWS
- Molecular cell biology of androgen receptor signalling
- (2009) Nigel C. Bennett et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mechanism of androgen receptor action
- (2009) Jin Li et al. MATURITAS
- Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
- (2009) Aimee L. Jackson et al. NATURE REVIEWS DRUG DISCOVERY
- Castration-resistant prostate cancer: Targeting androgen metabolic pathways in recurrent disease
- (2009) Elahe A. Mostaghel et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Progression of prostate cancer: Multiple pathways to androgen independence
- (2008) Hong-Lin Devlin et al. CANCER LETTERS
- Transcription Factor Stat5 Synergizes with Androgen Receptor in Prostate Cancer Cells
- (2008) S.-H. Tan et al. CANCER RESEARCH
- Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer
- (2008) X. Ouyang et al. CANCER RESEARCH
- Transcription Factor Signal Transducer and Activator of Transcription 5 Promotes Growth of Human Prostate Cancer Cells In vivo
- (2008) A. Dagvadorj et al. CLINICAL CANCER RESEARCH
- In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors
- (2008) R. Snoek et al. CLINICAL CANCER RESEARCH
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More